Formune Vaccines

Platform
Technology

News and
Events

Welcome to Formune

Therapeutic vaccines based on the EDA platform We are a biotechnology company that was founded in October 2012 and based in Navarra, Spain. We are engaged in the development of targeted therapeutic vaccines for the treatment of cancer & chronic infections. Our technology platform employs recombinant proteins incorporating the Extra Domain A (EDA) from fibronectin, an endogenous ligand for Toll-Like Receptor 4 (TLR-4). EDA-antigen vaccines generate strong immune responses through specific targeting to TLR-4+ cells, DC stimulation/maturation and CTL activation. We are currently focused on developing our lead product, EDA-HPVE7, a therapeutic vaccine against Human Papilloma Virus (HPV)-associated malignancies. EDA-HPVE7 has already demonstrated excellent efficacy eliminating large tumours in relevant animal models.

Contact
Location

+34 948 31 61 57

info@formune.es

Vivero de innovación,

Polígono Mocholí,

Plaza Cein 5 - Of.T5

31110 Noain

(Navarra) Spain

Googlemaps location